Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-417-SE25 | 24-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $553.671 |
| 2980-411-AG25 | 21-11-2025 | Sylex Biomedica SpA | Recepcion Conforme | $456.960 |
| 2980-414-AG25 | 21-11-2025 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-415-AG25 | 21-11-2025 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-418-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $2.127.505 |
| 2980-885-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $11.172.757 |
| 2980-886-AG25 | 21-11-2025 | Novartis Chile S.A. | Recepcion Conforme | $6.396.431 |
| 2980-887-AG25 | 21-11-2025 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $4.748.100 |
| 2980-888-AG25 | 21-11-2025 | Novofarma Service S.A. | Recepcion Conforme | $1.559.747 |
| 2980-890-AG25 | 21-11-2025 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $4.748.100 |
| 2980-891-AG25 | 21-11-2025 | Scm Pharma SpA | Recepcion Conforme | $1.365.525 |
| 2980-892-AG25 | 21-11-2025 | Varifarma Chile SpA | Recepcion Conforme | $1.261.210 |
| 2980-893-AG25 | 21-11-2025 | Novofarma Service S.A. | Recepcion Conforme | $5.950.119 |
| 2980-894-AG25 | 21-11-2025 | Novofarma Service S.A. | Recepcion Conforme | $5.950.119 |
| 2980-896-AG25 | 21-11-2025 | Dr. Reddys Laboratories Chile SpA | Recepcion Conforme | $4.341.120 |
| 2980-901-AG25 | 21-11-2025 | Novartis Chile S.A. | Recepcion Conforme | $5.885.759 |
| 2980-904-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $13.591.135 |
| 2980-905-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $56.387 |
| 2980-906-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.139.422 |
| 2980-907-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $12.147.665 |
| 2980-908-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.146.522 |
| 2980-909-SE25 | 21-11-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $523.065 |
| 2980-910-AG25 | 21-11-2025 | Synthon Chile Limitada | Recepcion Conforme | $6.246.072 |
| 2980-911-AG25 | 21-11-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $6.669.902 |
| 2980-914-AG25 | 21-11-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-915-AG25 | 21-11-2025 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-916-AG25 | 21-11-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $6.669.902 |
| 2980-917-AG25 | 21-11-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.002.427 |
| 2980-918-AG25 | 21-11-2025 | Astrazeneca S.A. | Recepcion Conforme | $1.897.762 |
| 2980-412-AG25 | 19-11-2025 | Alpha Pharma SpA | Aceptada | $434.112 |
